This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Marsh & McLennan's Units Sign Pact with Evident, Morningstar
by Zacks Equity Research
Marsh & McLennan's (MMC) units tie up with companies to boost portfolio and provide convenient digital solutions to customers.
Top Stock Reports for Philip Morris, PayPal & Dominion Energy
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Philip Morris (PM), PayPal (PYPL), and Dominion Energy (D).
Growing Cyber Crime Presents New Opportunity for Insurers
by Sapna Bagaria
A new market opportunity, cyber insurance, is providing insurers enough scope of growth.
Marsh & McLennan (MMC) Gets Rating Actions, Outlook Down
by Zacks Equity Research
Moody's affirms the ratings of Marsh & McLennan (MMC). The outlook for the same changes to negative.
Marsh & McLennan to Buy Jardine Lloyd for Portfolio Boost
by Zacks Equity Research
Marsh & McLennan (MMC) okays Jardine Lloyd's acquisition to enrich capabilities and drive overall growth.
Marsh & McLennan's (MMC) Unit Launches Advisory Offering
by Zacks Equity Research
Marsh & McLennan's (MMC) arm extends advisory offering to guide users through InsurTech market.
The Zacks Analyst Blog Highlights: Petrobras, Enterprise Products, Marsh & McLennan, Carnival and Valero
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Petrobras, Enterprise Products, Marsh & McLennan, Carnival and Valero
Top Analyst Reports for Petrobras, Enterprise Products and Marsh & McLennan
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Petrobras (PBR), Enterprise Products Partners (EPD) and Marsh & McLennan (MMC)
Marsh & McLennan's Unit to Buy Summit and Pavilion
by Zacks Equity Research
Marsh & McLennan's (MMC) unit Mercer to buy Summit and Pavilion for its consulting business.
Marsh & McLennan's (MMC) Q2 Earnings Miss Estimates, Up Y/Y (revised)
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 results suffer a rise in expenses, which outdoes revenue growth.
Marsh & McLennan's (MMC) Q2 Earnings Miss Estimates, Up Y/Y
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 results suffer a rise in expenses, which outdoes revenue growth.
Marsh & McLennan (MMC) Lags Q2 Earnings Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of -0.90% and 0.50%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
Marsh & McLennan's (MMC) Q2 Earnings Miss, Revenue in Line
by Zacks Equity Research
Marsh & McLennan's (MMC) Q2 results suffered from a rise in expense that outpaced revenue growth.
Insurance Stocks' Earnings Due on Jul 26: CINF, HIG & More
by Zacks Equity Research
Benign catastrophe loss, strong operating environment and a solid capital position favor insurers this earnings season.
Aon's (AON) to Report Q2 Earnings: Is a Beat in the Cards?
by Zacks Equity Research
Aon (AON)'s second-quarter earnings is likely to benefit from its strategic investments and a better portfolio mix.
Can Marsh & McLennan (MMC) Deliver a Beat in Q2 Earnings?
by Zacks Equity Research
Marsh & McLennan (MMC) is likely to ride high in Q2 on the back of robust revenues.
Marsh & McLennan Arm Buyout to Boost Construction Abilities
by Zacks Equity Research
Marsh & McLennan's (MMC) arm ramps up the company's inorganic growth profile to upgrade construction capabilities in Minnesota, upper Midwest and the Washington DC region.
Marsh & McLennan's Arm Inks Deal to Buy Wortham Insurance
by Zacks Equity Research
Marsh & McLennan's (MMC) arm to acquire independent insurance brokerage firm Wortham Insurance and widen its base in Texas.
Why Is Marsh & McLennan (MMC) Down 1.5% Since its Last Earnings Report?
by Zacks Equity Research
Marsh & McLennan (MMC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
6 Reasons to Hold Marsh & McLennan (MMC) in Your Portfolio
by Zacks Equity Research
Marsh & McLennan (MMC) emerges as a prudent pick for investors' portfolio as the stock assures better returns, banking on six factors.
Willis Towers (WLTW) Q1 Earnings Surpass, Guidance Intact
by Zacks Equity Research
Willis Towers (WLTW) Q1 displays better performance across all its segments.
Top Research Reports for Texas Instruments, Union Pacific & Mondelez
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Texas Instruments (TXN), Union Pacific (UNP) and Mondelez (MDLZ).
Marsh & McLennan (MMC) Beats Q1 Earnings and Revenues
by Anupama Mukhopadhyay
Marsh & McLennan came out with adjusted earnings of $1.38 per share, which beat the Zacks Consensus Estimate of $1.30.
Can Marsh & McLennan (MMC) Q1 Earnings Beat on Revenues?
by Zacks Equity Research
Higher revenues backed by a solid segmental performance might aid Marsh & McLennan (MMC) to beat on earnings in Q1.
Top Research Reports for Facebook, UnitedHealth & Pfizer
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), UnitedHealth (UNH) and Pfizer (PFE).